Vol. 11 No. 1: January-December 2024

Published: 2024-01-09

Original Research Articles

  • The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain

    Maria Merino, Paulina Maravilla-Herrera, Teresa Martín Lorenzo, Juan Antonio Arance, Julio Bobes, Montse Corrales, Fátima Guzmán, María Morales, Carlos Mur
    82-93
    DOI: https://doi.org/10.33393/grhta.2024.2697

  • Regional Formularies in Italy: current state and future perspectives

    Alberto Bortolami, Claudio Jommi, Filippo Bresciani, Luca Piccoli, Elisa Sangiorgi, Giovanna Scroccaro
    68-74
    DOI: https://doi.org/10.33393/grhta.2024.2677

  • Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis

    Flavio Caprioli, Massimo Claudio Fantini, Francesca Marando, Dario Scaduto, Roberto Ravasio
    55-67
    DOI: https://doi.org/10.33393/grhta.2024.2658

  • Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy

    Andrea Chiricozzi, Antonio Costanzo, Anna Levi, Federica Parretta, Roberto Ravasio
    38-50
    DOI: https://doi.org/10.33393/grhta.2024.2728

  • Clinical and economic burden of peristomal skin complications: Activity Based Costing analysis

    Agostino Fortunato, Filippo Rumi, Massimo Zazzetta, Marco Della Valle, Vincenzo Pedace, Americo Cicchetti
    31-37
    DOI: https://doi.org/10.33393/grhta.2024.2639

  • Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)

    Silvia Calabria, Manenti Lucio, Giulia Ronconi, Carlo Piccinni, Leonardo Dondi, Letizia Dondi, Antonella Pedrini, Immacolata Esposito, Alice Addesi, Filippo Aucella, Nello Martini
    22-30
    DOI: https://doi.org/10.33393/grhta.2024.2696

  • A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas

    Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti
    1-16
    DOI: https://doi.org/10.33393/grhta.2024.2601

Point of View

  • The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

    Mickaël Hiligsmann, Olivier Bruyère
    75-81
    DOI: https://doi.org/10.33393/grhta.2024.2682

  • HTA regulation: how is Italy moving?

    Francesca Patarnello
    51-54
    DOI: https://doi.org/10.33393/grhta.2024.3025

  • The future of drugs distribution in the National Health System

    Massimo Medaglia, Giuliano Buzzetti, Marco Cossolo, Paola Deambrosis, Giovanna Scroccaro
    17-21
    DOI: https://doi.org/10.33393/grhta.2024.2619